tiprankstipranks
Trending News
More News >
Capricor Therapeutics (CAPR)
NASDAQ:CAPR
Advertisement

Capricor Therapeutics (CAPR) Similar Stocks

Compare
1,138 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Capricor Therapeutics
$6.18
$283.45M
-3.77
-71.20%
6 Buy
0 Hold
0 Sell
Strong Buy
Galectin Therapeutics
$5.10
$335.04M
-7.92
104.82%
1 Buy
0 Hold
0 Sell
Moderate Buy
Alector
$1.50
$151.82M
-70.41%
1 Buy
6 Hold
2 Sell
Hold
I-MAB
$4.70
$334.19M
294.96%
4 Buy
0 Hold
0 Sell
Strong Buy
4D Molecular Therapeutics
$11.34
$529.61M
43.17%
8 Buy
0 Hold
1 Sell
Strong Buy
Humacyte
$1.71
$320.23M
-69.00%
5 Buy
0 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
CAPR
Capricor Therapeutics
6.18
-15.28
-71.20%
GALT
Galectin Therapeutics
5.10
2.61
104.82%
ALEC
Alector
1.50
-3.57
-70.41%
IMAB
I-MAB
4.70
3.51
294.96%
FDMT
4D Molecular Therapeutics
12.27
3.70
43.17%
HUMA
Humacyte
1.68
-3.74
-69.00%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis